/Investor DB

Curie.Bio — 2024 Investments

2 investments dated 2024 · listed companies and verified rows first · show all

Relayrelaytx.comin𝕏NASDAQ: RLAYJan 2024SEC filingmedium confidence

Relay Therapeutics develops the Dynamo platform, which applies motion-based drug design principles to discover therapeutic drugs by integrating protein dynamics simulations with experimental and computational techniques.

AI & Machine LearningBiotechDeep TechCambridge, US

Donald A. Bergstrom(Executive Officer)inSanjiv K. Patel(Director, President and Chief Executive Officer)inSekar Kathiresan(Director)Douglas S. Ingram(Director)Mark Murcko(Director)Laura Shawver(Director)

Board seatAlexis Borisy· per SEC Form D · $30M raise · filed Jan 2024

Co-investorsCommonweal VenturesEcoR1 CapitalForesite CapitalNat TurnerNextech InvestSoftBank Vision Fund+2 more

Zealzeal.comin𝕏Oct 2024

Zeal is an embedded payroll and workforce payments platform for staffing companies, labor marketplaces, and workforce management tools.

FintechHR TechSaaSSan Francisco, US

Pranab Krishnan(Founder)inKirti Shenoy(Founder)inJonathan MairenaHenry Guillen(Founding Engineer)Alex Dees(Partner Growth Manager)Grace Turner(Lead Recruiter)

Co-investorsCommerce VenturesSpark CapitalBoxGroupCohen CircleLorimer VenturesY Combinator+15 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.